IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,177,321 | +2040.6% | 239,055 | +957.8% | 0.00% | – |
Q2 2023 | $428,722 | +72.4% | 22,600 | +40.9% | 0.00% | – |
Q1 2023 | $248,734 | -16.9% | 16,037 | -4.9% | 0.00% | – |
Q4 2022 | $299,301 | +236.3% | 16,862 | +5.2% | 0.00% | – |
Q3 2022 | $89,000 | +41.3% | 16,034 | -1.3% | 0.00% | – |
Q2 2022 | $63,000 | -38.8% | 16,243 | -13.1% | 0.00% | – |
Q1 2022 | $103,000 | -32.7% | 18,700 | +4.0% | 0.00% | – |
Q4 2021 | $153,000 | -15.9% | 17,989 | -14.0% | 0.00% | – |
Q3 2021 | $182,000 | -98.0% | 20,924 | -97.6% | 0.00% | -100.0% |
Q2 2021 | $9,111,000 | -33.9% | 862,013 | +0.3% | 0.00% | -50.0% |
Q1 2021 | $13,792,000 | -73.5% | 859,862 | -23.7% | 0.00% | -73.3% |
Q4 2020 | $52,078,000 | +505.0% | 1,127,487 | +360.9% | 0.02% | +400.0% |
Q3 2020 | $8,608,000 | +135.9% | 244,625 | +63.2% | 0.00% | +200.0% |
Q2 2020 | $3,649,000 | – | 149,849 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |